Literature DB >> 11022025

Fetal alcohol syndrome (FAS) primary prevention through FAS diagnosis: I. Identification of high-risk birth mothers through the diagnosis of their children.

S J Astley1, D Bailey, C Talbot, S K Clarren.   

Abstract

A 5-year, fetal alcohol syndrome (FAS) primary prevention study was conducted in Washington State to: (1) assess the feasibility of using a FAS diagnostic and prevention clinic as a centre for identifying and targeting primary prevention intervention to high-risk women (namely women who had given birth to a child with FAS); (2) generate a comprehensive, lifetime profile of these women; (3) identify factors that have enhanced and/or hindered their ability to achieve abstinence. The results of this study are presented in two parts: work on objective 1 is summarized in the present paper; whereas that on objectives 2 and 3 is summarized in the accompanying paper. This project demonstrated that a multidisciplinary FAS Diagnostic and Prevention Network (FAS DPN) clinic could successfully attract and meet the diagnostic and treatment planning needs of patients presenting with prenatal alcohol exposure. One out of every three patients evaluated in the FAS DPN clinics was diagnosed with FAS or static encephalopathy/alcohol exposed. The birth mothers of one out of every three of these children diagnosed with FAS or static encephalopathy/alcohol exposed could be located and directly contacted. Half of the birth mothers directly contacted were still at risk for producing more children damaged by prenatal alcohol exposure. Thus, one out of every 18 children evaluated in the FAS DPN clinics had a birth mother who could be found and was at risk of producing more children damaged by prenatal alcohol exposure. Primary prevention programmes targeted to this high-risk population could lead to measurable, cost-effective reductions in the incidence of FAS. Using this approach, the cost of raising a child with FAS would be roughly 30 times the cost of preventing FAS in the child. The benefit to the children, their mothers, and society would be immeasurable.

Entities:  

Mesh:

Year:  2000        PMID: 11022025     DOI: 10.1093/alcalc/35.5.499

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  16 in total

1.  Alcohol use and abuse in pregnancy: an evaluation of the merits of screening.

Authors:  Matt Hicks; Reginald S Sauve; Andrew W Lyon; Margaret Clarke; Suzanne Tough
Journal:  Can Child Adolesc Psychiatr Rev       Date:  2003-08

2.  Brief Report: Burden of Care in Mothers of Children with Autism Spectrum Disorder or Intellectual Disability.

Authors:  Jenny Fairthorne; Nick de Klerk; Helen Leonard
Journal:  J Autism Dev Disord       Date:  2016-03

3.  Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis.

Authors:  Albert E Chudley; Julianne Conry; Jocelynn L Cook; Christine Loock; Ted Rosales; Nicole LeBlanc
Journal:  CMAJ       Date:  2005-03-01       Impact factor: 8.262

Review 4.  Preventing fetal alcohol spectrum disorders. Preconception counseling and diagnosis help.

Authors:  Suzanne C Tough; Margaret Clarke; Sterling Clarren
Journal:  Can Fam Physician       Date:  2005-09       Impact factor: 3.275

5.  The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.

Authors:  Ludmila N Bakhireva; Renate D Savich; Dennis W Raisch; Sandra Cano; Robert D Annett; Lawrence Leeman; Mahek Garg; Chelsea Goff; Daniel D Savage
Journal:  Alcohol Clin Exp Res       Date:  2013-02-19       Impact factor: 3.455

6.  Overview of fetal alcohol spectrum disorders for mental health professionals.

Authors:  Margaret E Clarke; W Benton Gibbard
Journal:  Can Child Adolesc Psychiatr Rev       Date:  2003-08

7.  The Lililwan Project: study protocol for a population-based active case ascertainment study of the prevalence of fetal alcohol spectrum disorders (FASD) in remote Australian Aboriginal communities.

Authors:  James P Fitzpatrick; Elizabeth J Elliott; Jane Latimer; Maureen Carter; June Oscar; Manuela Ferreira; Heather Carmichael Olson; Barbara Lucas; Robyn Doney; Claire Salter; Elizabeth Peadon; Genevieve Hawkes; Marmingee Hand
Journal:  BMJ Open       Date:  2012-05-03       Impact factor: 2.692

8.  Cost of fetal alcohol spectrum disorder diagnosis in Canada.

Authors:  Svetlana Popova; Shannon Lange; Larry Burd; Albert E Chudley; Sterling K Clarren; Jürgen Rehm
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

9.  Development of a reliable questionnaire to assist in the diagnosis of Fetal Alcohol Spectrum Disorders (FASD).

Authors:  James P Fitzpatrick; Jane Latimer; Manuela Ferreira; Alexandra L C Martiniuk; Elizabeth Peadon; Maureen Carter; June Oscar; Emily Carter; Meredith Kefford; Rhonda Shandley; Harry Yungabun; Elizabeth J Elliott
Journal:  BMC Pediatr       Date:  2013-03-07       Impact factor: 2.125

10.  Recommendations from a consensus development workshop on the diagnosis of fetal alcohol spectrum disorders in Australia.

Authors:  Rochelle E Watkins; Elizabeth J Elliott; Amanda Wilkins; Raewyn C Mutch; James P Fitzpatrick; Janet M Payne; Colleen M O'Leary; Heather M Jones; Jane Latimer; Lorian Hayes; Jane Halliday; Heather D'Antoine; Sue Miers; Elizabeth Russell; Lucinda Burns; Anne McKenzie; Elizabeth Peadon; Maureen Carter; Carol Bower
Journal:  BMC Pediatr       Date:  2013-10-02       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.